Cargando…
Treatment of rheumatic diseases and hepatitis B virus coinfection
We often encounter rheumatological patients coinfected with hepatitis B in daily practice. In this paper, we will discuss the basic characteristics of the virus of hepatitis B, course of infection, the safety of rituximab, tocilizumab, abatacept treatment and therapeutic recommendations in managemen...
Autores principales: | Felis-Giemza, Anna, Olesińska, Marzena, Świerkocka, Katarzyna, Więsik-Szewczyk, Ewa, Haładyj, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335127/ https://www.ncbi.nlm.nih.gov/pubmed/25549599 http://dx.doi.org/10.1007/s00296-014-3195-8 |
Ejemplares similares
-
Antimalarials – are they effective and safe in rheumatic diseases?
por: Haładyj, Ewa, et al.
Publicado: (2018) -
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome
por: Haładyj, Ewa, et al.
Publicado: (2016) -
Relationship between type of skin lesions and nailfold capillaroscopy pattern in mixed connective tissue disease
por: Felis-Giemza, Anna, et al.
Publicado: (2021) -
IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
por: Wojdasiewicz, Piotr, et al.
Publicado: (2019) -
Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)